ALEC · CIK 0001653087 · FY2025 live · 2025-12-31
Alector, Inc.
View as
Model
Classic Z
FY2025
−5.45
Zone
Distress
Prior
—
Market DD
—
1y PD
—
Meridian Rank
17.64
0–100 · Classic Z tape · not a PD
Book standing
16
Year change
—
Market PD
—
O-score
22
Events on this name
Same published rows as Today. Not a live recompute.
MARKET PD UNAVAILABLE
watch · 41
- mertonPd: — → —
−5.45
Z″ −9.85
Score −5.45 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.671.2 × = 0.81X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−3.311.4 × = −4.64X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.533.3 × = −1.76X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
0.120.6 × = 0.07X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.071 × = 0.07
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
Alector, Inc. is on classic Z at −5.45 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 28th percentile in Healthcare.
- BFRIDistressBiofrontera Inc.−5.51
- SLDBDistressSolid Biosciences Inc.−5.37
- FHTXDistressFoghorn Therapeutics Inc.−5.34
- HURADistressTuHURA Biosciences, Inc./NV−5.33
- PBYIDistressPUMA BIOTECHNOLOGY, INC.−5.32
- ABVCDistressABVC BIOPHARMA, INC.−5.58
- CRVSDistressCorvus Pharmaceuticals, Inc.−5.58
- DRIODistressDarioHealth Corp.−5.60
KPI widgets
Current assets
$266M
Total assets
$293M
Current liabilities
$70M
Total liabilities
$263M
Working capital
$197M
Retained earnings
−$972M
EBIT
−$156M
Total sales
$21M
Book equity
$31M
Accession 0001193125-26-071593. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 13 Sept 2026.